Mutations in the thymidine kinase gene that allow expression of the enzyme in quiescent (G0) cells.

Abstract:

:Thymidine kinase (TK) is a nucleotide salvage pathway enzyme whose activity is highly dependent on the growth state and cell cycle phase of a cell. Cells in the resting or quiescent (G0) phase express very low levels of TK mRNA and protein. When quiescent cells are stimulated to enter the cell cycle by the addition of serum, TK mRNA, activity and polypeptide increase coordinately after about 10-15 h, at the beginning of S phase. When growth-independent heterologous promoters are substituted for the natural TK promoter, TK mRNA can be expressed in quiescent cells. Despite the presence of TK mRNA in such G0 cells, there is little expression of TK polypeptide; the normal increase in enzyme at S phase is observed following serum stimulation. Deletion of the introns and 3' untranslated sequences does not affect the expression of the TK gene in serum stimulation experiments. In contrast, deletion of the C-terminal 40 amino acids or fusion of a small segment of a beta-galactosidase to the C-terminus overcomes the block to expression of the TK polypeptide in G0 cells. These C-terminal alterations are the same as those which lead to constitutive expression of TK during the cell cycle of proliferating cells, suggesting that mechanisms which control the levels of TK in cycling cells may also operate in quiescent cells.

journal_name

Oncogene

journal_title

Oncogene

authors

Kauffman MG,Rose PA,Kelly TJ

subject

Has Abstract

pub_date

1991-08-01 00:00:00

pages

1427-35

issue

8

eissn

0950-9232

issn

1476-5594

journal_volume

6

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting.

    abstract::NIH sponsored a meeting of medical and veterinary pathologists with mammary gland expertise in Annapolis in March 1999. Rapid development of mouse mammary models has accentuated the need for definitions of the mammary lesions in genetically engineered mice (GEM) and to assess their usefulness as models of human breast...

    journal_title:Oncogene

    pub_type: 共识发展会议,杂志文章,评审

    doi:10.1038/sj.onc.1203277

    authors: Cardiff RD,Anver MR,Gusterson BA,Hennighausen L,Jensen RA,Merino MJ,Rehm S,Russo J,Tavassoli FA,Wakefield LM,Ward JM,Green JE

    更新日期:2000-02-21 00:00:00

  • Indistinct cell cycle checkpoint after u.v. damage in H-ras-transformed mouse liver cells despite normal p53 gene expression.

    abstract::Growth arrest after u.v. damage was investigated in C3H mouse primary cultured hepatocytes, spontaneously immortalized liver epithelial cells and their H-ras-transformed derivatives. All cells except for one of the transformed lines had the wild type p53 gene considered necessary for the G1-S checkpoint. Growth arrest...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Kadohama T,Tsuji K,Ogawa K

    更新日期:1994-10-01 00:00:00

  • Hyperplasia, hyperkeratosis and benign tumor production in transgenic mice by a targeted v-fos oncogene suggest a role for fos in epidermal differentiation and neoplasia.

    abstract::A vector, derived from the human K1 keratin gene, has been employed to target v-fos expression exclusively in the epidermis of transgenic mice. Adult transgenic mice expressors (3-4 months) displayed hyperplasia and hyperkeratosis, initially in wounded (tagged) ears, which later became bilateral. This phenotype appear...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Greenhalgh DA,Rothnagel JA,Wang XJ,Quintanilla MI,Orengo CC,Gagne TA,Bundman DS,Longley MA,Fisher C,Roop DR

    更新日期:1993-08-01 00:00:00

  • FYN promotes mesenchymal phenotypes of basal type breast cancer cells through STAT5/NOTCH2 signaling node.

    abstract::Basal type breast cancer is the most aggressive and has mesenchymal features with a high metastatic ability. However, the signaling node that determines the basal type features in breast cancer remains obscure. Here, we report that FYN among SRC family kinases is required for the maintenance of basal type breast cance...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-017-0114-y

    authors: Lee GH,Yoo KC,An Y,Lee HJ,Lee M,Uddin N,Kim MJ,Kim IG,Suh Y,Lee SJ

    更新日期:2018-04-01 00:00:00

  • Interaction between p53 and TGF beta 1 in control of epithelial cell proliferation.

    abstract::Although loss of sensitivity to transforming growth factor beta (TGF beta) may be a key step in the escape of epithelial tumours from normal growth control, the intracellular signals determining responsiveness remain controversial, particularly the role of p53. We have investigated this question using thyroid epitheli...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Blaydes JP,Schlumberger M,Wynford-Thomas D,Wyllie FS

    更新日期:1995-01-19 00:00:00

  • Cloning of the human Gfi-1 gene and its mapping to chromosome region 1p22.

    abstract::Recently the rat and mouse Growth Factor Independence (Gfi-1) genes have been cloned (Gilks et al., 1993; Zoring et al; 1996). This gene allows cells in culture to overcome the depletion of growth factors in the culture medium and maintain their proliferative potential. As part of a cloning strategy to isolated genes ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1200910

    authors: Roberts T,Cowell JK

    更新日期:1997-02-27 00:00:00

  • Failure of senescent cells to phosphorylate the RB protein.

    abstract::The product of the RB susceptibility gene has been shown to be differentially phosphorylated during the cell cycle, suggesting a role in the regulation of cell cycle progression. We examined the expression and phosphorylation status of the RB protein in senescent Syrian hamster embryo cells. Both phosphorylated and un...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Futreal PA,Barrett JC

    更新日期:1991-07-01 00:00:00

  • Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25.

    abstract::The high incidence of loss of chromosome 10 alleles in glioblastoma multiforme suggests the presence on this chromosome of a tumor suppressor gene that is important in glioma tumorigenesis and progression. Our initial deletion mapping studies using restriction fragment length polymorphism markers indicated a common de...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Rasheed BK,McLendon RE,Friedman HS,Friedman AH,Fuchs HE,Bigner DD,Bigner SH

    更新日期:1995-06-01 00:00:00

  • LncRNA-mediated regulation of cell signaling in cancer.

    abstract::To date, a large number of long non-coding RNAs (lncRNAs) have been recently discovered through functional genomics studies. Importantly, lncRNAs have been shown, in many cases, to function as master regulators for gene expression and thus, they can play a critical role in various biological functions and disease proc...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2017.184

    authors: Peng WX,Koirala P,Mo YY

    更新日期:2017-10-12 00:00:00

  • Role of the adaptor protein LNK in normal and malignant hematopoiesis.

    abstract::The signal transduction pathways, orchestrating the differentiation of hematopoietic stem and progenitor cells in response to cytokine stimulation, are strictly controlled by networks of feedback loops, highly selective protein interactions and finely tuned on/off switches. In hematological malignancies, the aberrant ...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2012.435

    authors: Gery S,Koeffler HP

    更新日期:2013-06-27 00:00:00

  • c-fos and c-jun overexpression in malignant cells reduces their tumorigenic and metastatic potential, and affects their MHC class I gene expression.

    abstract::Reduced co-expression of the c-fos and c-jun protooncogenes has been correlated with the down regulation of H-2K class I major histocompatibility antigens in high-metastatic cell lines from the Lewis lung carcinoma, B16 melanoma and the K1735 melanoma. Transfection of c-jun and c-fos genes into the high metastatic clo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Yamit-Hezi A,Plaksin D,Eisenbach L

    更新日期:1994-04-01 00:00:00

  • Identifying targets for the restoration and reactivation of BRM.

    abstract::Brahma (BRM) is a novel anticancer gene, which is frequently inactivated in a variety of tumor types. Unlike many anticancer genes, BRM is not mutated, but rather epigenetically silenced. In addition, histone deacetylase complex (HDAC) inhibitors are known to reverse BRM silencing, but they also inactivate it via acet...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.613

    authors: Kahali B,Gramling SJ,Marquez SB,Thompson K,Lu L,Reisman D

    更新日期:2014-01-30 00:00:00

  • HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer.

    abstract::Hepatitis B virus (HBV) infection is a major risk factor worldwide for the development of hepatocellular carcinoma (HCC). Integrated HBV DNA fragments, often highly rearranged, are frequently detected in HCC. In woodchuck, the viral enhancer plays a central role in hepatocarcinogenesis, but in humans the mechanism of ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204879

    authors: Shamay M,Agami R,Shaul Y

    更新日期:2001-10-18 00:00:00

  • TAS4464, a NEDD8-activating enzyme inhibitor, activates both intrinsic and extrinsic apoptotic pathways via c-Myc-mediated regulation in acute myeloid leukemia.

    abstract::TAS4464, a potent, selective small molecule NEDD8-activating enzyme (NAE) inhibitor, leads to inactivation of cullin-RING E3 ubiquitin ligases (CRLs) and consequent accumulations of its substrate proteins. Here, we investigated the antitumor properties and action mechanism of TAS4464 in acute myeloid leukemia (AML). T...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01586-4

    authors: Ochiiwa H,Ailiken G,Yokoyama M,Yamagata K,Nagano H,Yoshimura C,Muraoka H,Ishida K,Haruma T,Nakayama A,Hashimoto N,Murata K,Nishimura M,Kawashima Y,Ohara O,Ohkubo S,Tanaka T

    更新日期:2021-01-08 00:00:00

  • Cytotoxic drug-induced, p53-mediated upregulation of caspase-8 in tumor cells.

    abstract::Apoptosis resistance is crucially involved in cancer development and progression, represents the leading cause for failure of anticancer therapy and is caused, for example, by downregulation of proapoptotic intracellular signaling molecules such as caspase-8. We found that the cytotoxic drugs methotrexate (MTX) and 5-...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210666

    authors: Ehrhardt H,Häcker S,Wittmann S,Maurer M,Borkhardt A,Toloczko A,Debatin KM,Fulda S,Jeremias I

    更新日期:2008-01-31 00:00:00

  • Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies.

    abstract::Apoptin, a protein of the chicken anemia virus (CAV), represents a novel potential anticancer therapeutic, because it induces apoptotic death specifically in tumor but not normal cells. The cellular localization appears to be crucial for apoptin's selective toxicity. In normal cells apoptin remains in the cytoplasm, w...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209923

    authors: Janssen K,Hofmann TG,Jans DA,Hay RT,Schulze-Osthoff K,Fischer U

    更新日期:2007-03-08 00:00:00

  • Serum induction of the fibroblast growth factor-binding protein (FGF-BP) is mediated through ERK and p38 MAP kinase activation and C/EBP-regulated transcription.

    abstract::The fibroblast growth factor-binding protein (FGF-BP) modulates FGF activity through binding and release from the extracellular matrix. Consequently, the expression of FGF-BP in certain tumor types is a rate-limiting regulator of FGF-mediated angiogenesis. FGF-BP is upregulated in squamous cell carcinoma by treatment ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204249

    authors: Harris VK,Kagan BL,Ray R,Coticchia CM,Liaudet-Coopman ED,Wellstein A,Tate Riegel A

    更新日期:2001-03-29 00:00:00

  • Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21.

    abstract::The death mediator caspase acts as the dominant regulator during cell death induction. The CPP32 subfamily, including caspase 3 (CPP32/Yama/Apopain), is essential for the cell death signaling. We recently reported that activation of caspase 3 is regulated by complex formation with p21 or ILP. In the present study, we ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202409

    authors: Suzuki A,Tsutomi Y,Miura M,Akahane K

    更新日期:1999-02-04 00:00:00

  • The FoxO code.

    abstract::The FoxO family of Forkhead transcription factors plays an important role in longevity and tumor suppression by upregulating target genes involved in stress resistance, metabolism, cell cycle arrest and apoptosis. FoxO transcription factors translate a variety of environmental stimuli, including insulin, growth factor...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2008.21

    authors: Calnan DR,Brunet A

    更新日期:2008-04-07 00:00:00

  • The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53.

    abstract::The orphan nuclear receptor TR3 (NR41A and Nur77) is overexpressed in most lung cancer patients and is a negative prognostic factor for patient survival. The function of TR3 was investigated in non-small-cell lung cancer A549 and H460 cells, and knockdown of TR3 by RNA interference (siTR3) inhibited cancer cell growth...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.504

    authors: Lee SO,Andey T,Jin UH,Kim K,Singh M,Safe S

    更新日期:2012-07-05 00:00:00

  • Glutathione depletion-induced apoptosis of Ha-ras-transformed NIH3T3 cells can be prevented by melatonin.

    abstract::It is well known that intracellular antioxidant glutathione (GSH) plays major roles in the maintenance of redox status and defense of oxidative stress. Ras, a small GTP-binding protein, may send growth-stimulating message to the nucleus through downstream Rac oncoprotein and superoxide (O(2*-)). These findings led us ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206289

    authors: Chuang JI,Chang TY,Liu HS

    更新日期:2003-03-06 00:00:00

  • Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis.

    abstract::Growing evidence demonstrates that hepatitis B virus (HBV) integration and resulting insertional mutagenesis play an important role in cell growth or maintenance in hepatocellular carcinomas (HCCs). To determine if HBV integration occurs and affects cellular genes at such a stage of infection, we analysed viral-host j...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208628

    authors: Minami M,Daimon Y,Mori K,Takashima H,Nakajima T,Itoh Y,Okanoue T

    更新日期:2005-06-23 00:00:00

  • Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression.

    abstract::Transformed cells express high levels of non-telomeric reverse-transcriptase (RT) activity of retrotransposon and endogenous retrovirus origin. We previously reported that RT inhibition, either pharmacological or through transient silencing of RT-encoding LINE-1 (L1) elements by RNA interference (RNAi), reduced prolif...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210214

    authors: Oricchio E,Sciamanna I,Beraldi R,Tolstonog GV,Schumann GG,Spadafora C

    更新日期:2007-06-21 00:00:00

  • Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKS): evidence for a divergence of the ERKs and JNKs pathways induced by Ret.

    abstract::The RET proto-oncogene encodes a functional receptor tyrosine kinase (Ret) for the Glial cell line Derived Neurotrophic Factor (GDNF). RET is involved in several neoplastic and non-neoplastic human diseases. Oncogenic activation of RET is detected in human papillary thyroid tumours and in multiple endocrine neoplasia ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201778

    authors: Chiariello M,Visconti R,Carlomagno F,Melillo RM,Bucci C,de Franciscis V,Fox GM,Jing S,Coso OA,Gutkind JS,Fusco A,Santoro M

    更新日期:1998-05-14 00:00:00

  • Differential modulation of Myb family genes by Ets-2.

    abstract::The myb family of genes encodes highly homologous nuclear transcription factors that play distinct roles in the development of breast, germ cells and hematoid organs. While the mechanisms associated with the regulation of these genes remain unknown, the transactivation of c-Myb was previously shown to be upregulated b...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207537

    authors: Kang AD,Park G,Kim YH,Oh IH

    更新日期:2004-05-20 00:00:00

  • Cell type-specific responses of human cells to inhibition of replication licensing.

    abstract::Replication origins are 'licensed' for a single initiation event by loading Mcm2-7 complexes during late mitosis and G1. Licensing is blocked at other cell cycle stages by the activity of cyclin-dependent kinases and a small protein called geminin. Here, we describe the effects of over-expressing a non-degradable form...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205910

    authors: Shreeram S,Sparks A,Lane DP,Blow JJ

    更新日期:2002-09-26 00:00:00

  • The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression.

    abstract::The transcription factor NRF2 is the major mediator of oxidative stress responses and is closely connected to therapy resistance in tumors harboring activating mutations in the NRF2 pathway. In melanoma, such mutations are rare, and it is unclear to what extent melanomas rely on NRF2. Here we show that NRF2 suppresses...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01477-8

    authors: Jessen C,Kreß JKC,Baluapuri A,Hufnagel A,Schmitz W,Kneitz S,Roth S,Marquardt A,Appenzeller S,Ade CP,Glutsch V,Wobser M,Friedmann-Angeli JP,Mosteo L,Goding CR,Schilling B,Geissinger E,Wolf E,Meierjohann S

    更新日期:2020-10-01 00:00:00

  • Functional capabilities of molecular network components controlling the mammalian G1/S cell cycle phase transition.

    abstract::The molecular interactions implicated in the mammalian G1/S cell cycle phase transition comprise a highly nonlinear network which can produce seemingly paradoxical results and make intuitive interpretations unreliable. A new approach to this problem is presented, consisting of (1) a convention of unambiguous reaction ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201608

    authors: Kohn KW

    更新日期:1998-02-26 00:00:00

  • MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival.

    abstract::Gastric cancer (GC) is one of the most common tumors and the molecular mechanism underlying its metastasis is still largely unclear. Here, we show that miR-25 was overexpressed in plasma and primary tumor tissues of GC patients with tumor node metastasis stage (III or IV) or lymph node metastasis. MiR-25 inhibition si...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2014.214

    authors: Li BS,Zuo QF,Zhao YL,Xiao B,Zhuang Y,Mao XH,Wu C,Yang SM,Zeng H,Zou QM,Guo G

    更新日期:2015-05-14 00:00:00

  • Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins.

    abstract::We have examined the possibility that the E7 proteins of the high-risk human papillomavirus (HPV) type 16 and 18 and the oncogenic adenovirus (Ad) type 12 E1A protein share the ability to down-regulate the expression of components of the antigen processing and presentation pathway, as a common strategy in the evasion ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203860

    authors: Georgopoulos NT,Proffitt JL,Blair GE

    更新日期:2000-10-05 00:00:00